Pricing Log in Create free account

Biodesix, Inc. (BDSX) vs Exagen Inc. (XGN)

Biodesix, Inc. and Exagen Inc. are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $209.3M against $184.1M — 1.1× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 31.2% against 20.8%. Biodesix, Inc. has the higher net margin (−25.7% vs −26.6%) and the higher return on invested capital (−44.8% vs −68.3%). Across the 18 metrics below, Biodesix, Inc. leads on 9 and Exagen Inc. on 9.

Valuation

Metric BDSX XGN Diagnostics & Research median
P/E n/m n/m 34.52
P/S 2.01 2.56 4.24
P/B 24.38 14.88 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 2.19 2.55 5.18
Earnings yield (13.91%) (10.77%) (1.50%)
Free cash flow yield (9.11%) (4.17%) 0.00%

Profitability

Metric BDSX XGN Diagnostics & Research median
Gross margin 0.00% 58.64% 48.32%
Operating margin (18.69%) (18.58%) (5.68%)
Net margin (25.74%) (26.61%) (4.10%)
Free cash flow margin (18.30%) (10.66%) 0.00%
Return on equity (778.89%) (113.82%) 0.00%
Return on assets (29.65%) (34.19%) (6.05%)
Return on invested capital (44.84%) (68.33%) 0.00%

Growth

Metric BDSX XGN Diagnostics & Research median
Revenue growth (TTM) 31.23% 20.83% 8.99%
EPS growth (last fiscal year) 29.24% (12.05%) 20.36%
Revenue growth, 5-year CAGR 14.20% 9.66% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX XGN Diagnostics & Research median
Debt to equity 5.43 2.00 0.01
Current ratio 2.96 3.18 2.27
Net debt to EBITDA (1.36) 0.68 0.68

Dividend

Metric BDSX XGN Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric BDSX XGN Diagnostics & Research median
Market cap 209.33m 184.11m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack